Browsing by Author "Paunovic, Ivana (57197090935)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Does Atrial Fibrillation at Diagnosis Change Prognosis in Patients with Aortic Stenosis?(2024) ;Petrovic, Olga (33467955000) ;Vidanovic, Stasa (59217946400) ;Jovanovic, Ivana (57223117334) ;Paunovic, Ivana (57197090935) ;Rakocevic, Ivana (57199519440) ;Milasinovic, Dejan (24823024500) ;Tesic, Milorad (36197477200) ;Boskovic, Nikola (6508290354) ;Dukic, Djordje (57919369500) ;Ostojic, Marina (56810816200) ;Vratonjic, Jelena (57216883910) ;Mladenovic, Aleksandra (59196797900)Trifunovic-Zamaklar, Danijela (9241771000)Background: Aortic stenosis (AS) is a common valve disease and atrial fibrillation (AF) is the most common cardiac arrhythmia, frequently associated with AS. This study aimed to evaluate the impact of AF on mortality in patients with moderate and severe AS. Methods: We retrospectively analyzed 1070 consecutive moderate and severe AS patients (57% were male, age was 69 ± 10, severe AS 22.5%), who underwent transthoracic echocardiography from March 2018 to November 2021. AS severity was defined by specific threshold values with severe AS being defined by a peak velocity > 4 m/s, an MPG > 40 mmHg, and an AVA < 1 cm2 and moderated by a peak velocity of 3–4 m/s, an MPG 20–40 mmHg and an AVA 1–1.5 cm. Patients with AF were defined as those having a history of AF when AS was found on the index echocardiography. The follow-up assessment in December 2023 ascertained vital status and data on aortic valve replacement (AVR). Results: 790 (73.8%) patients were with sinus rhythm (SR) and 280 (26.2%) patients with AF. Mortality was higher in patients with AF than in those with SR (46% vs. 36.2% HR 1.424, 95% CI 1.121–1.809, p = 0.004). After adjusting for clinical confounders, mortality risk in AF relative to SR remained significant (HR 1.284, 95% CI 1.03–1.643, p = 0.047). Patients with AF demonstrated high mortality risk in the moderate aortic stenosis stratum (HR 1.376, 95% CI 1.059–1.788, p = 0.017), with even greater risk in the severe AS stratum (HR 1.644, 95% CI 1.038–2.603, p = 0.034) with significant interaction (p = 0.007). In patients with AF AVR demonstrated a protective effect on survival (HR 0.365, 95% CI 0.202–0.627, p < 0.001), but to a lesser degree than in patients with sinus rhythm (HR 0.376, 95% CI 0.250–0.561, p < 0.001) without significant interaction (p = 0.278). In patients with AF mortality risk was high in the conservative treatment stratum (HR 1.361, 95% CI 1.066–1.739, p = 0.014), in the AVR stratum mortality risk was higher but did not reach statistical significance (HR 1.823, 95% CI 0.973–3.414, p = 0.061). However, when corrected for echocardiographic variables strongly correlated with AF, AF was no longer independently associated with all-cause mortality. (HR 0.97 95% CI 0.709–1.323, p = 0.84). Conclusions: Patients with moderate and severe AS and AF have worse prognosis than patients with SR which can be explained by cardiac damage. AVR improves survival in patients with AF and with SR. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test(2013) ;Dobric, Milan (23484928600) ;Giga, Vojislav (55924460200) ;Beleslin, Branko (6701355424) ;Ignjatovic, Svetlana (55901270700) ;Paunovic, Ivana (57197090935) ;Stepanovic, Jelena (6603897710) ;Djordjevic-Dikic, Ana (57003143600) ;Kostic, Jelena (57159483500) ;Nedeljkovic, Ivana (55927577700) ;Nedeljkovic, Milan (7004488186) ;Tesic, Milorad (36197477200) ;Dajak, Marijana (6507116212)Ostojic, Miodrag (34572650500)Background: Glycogen phosphorylase BB (GPBB) is released from cardiac cells during myocyte damage. Previous studies have shown contradictory results regarding the relation of enzyme release and reversible myocardial ischemia. The aim of this study was to determine the plasma kinetics of GPBB as a response to the exercise stress echocardiographic test (ESET), and to define the relationship between myocardial ischemia and enzyme plasma concentrations. Methods: We studied 46 consecutive patients undergoing ESET, with recent coronary angiography. In all patients, a submaximal stress echo test according to Bruce protocol was performed. Concentration of GPBB was measured in peripheral blood that was sampled 5 min before and 10, 30 and 60 min after ESET. Results: There was significant increase of GPBB concentration after the test (p = 0.021). Significant increase was detected 30 min (34.9% increase, p = 0.021) and 60 min (34.5% increase, p = 0.016) after ESET. There was no significant effect of myocardial ischemia on GPBB concentrations (p = 0.126), and no significant interaction between sampling intervals and myocardial ischemia, suggesting a similar release profile of GPBB in ischemic and non-ischemic conditions (p = 0.558). Patients in whom ESET was terminated later (stages 4 or 5 of standard Bruce protocol; n = 13) had higher GPBB concentrations than patients who terminated ESET earlier (stages 1, 2 or 3; n = 33) (p = 0.049). Baseline GPBB concentration was not correlated to any of the patients' demographic, clinical and hemodynamic characteristics. Conclusions: GPBB plasma concentration increases after ESET, and it is not related to inducible myocardial ischemia. However, it seems that GPBB release during ESET might be related to exercise load/duration. - Some of the metrics are blocked by yourconsent settings
Publication Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test(2013) ;Dobric, Milan (23484928600) ;Giga, Vojislav (55924460200) ;Beleslin, Branko (6701355424) ;Ignjatovic, Svetlana (55901270700) ;Paunovic, Ivana (57197090935) ;Stepanovic, Jelena (6603897710) ;Djordjevic-Dikic, Ana (57003143600) ;Kostic, Jelena (57159483500) ;Nedeljkovic, Ivana (55927577700) ;Nedeljkovic, Milan (7004488186) ;Tesic, Milorad (36197477200) ;Dajak, Marijana (6507116212)Ostojic, Miodrag (34572650500)Background: Glycogen phosphorylase BB (GPBB) is released from cardiac cells during myocyte damage. Previous studies have shown contradictory results regarding the relation of enzyme release and reversible myocardial ischemia. The aim of this study was to determine the plasma kinetics of GPBB as a response to the exercise stress echocardiographic test (ESET), and to define the relationship between myocardial ischemia and enzyme plasma concentrations. Methods: We studied 46 consecutive patients undergoing ESET, with recent coronary angiography. In all patients, a submaximal stress echo test according to Bruce protocol was performed. Concentration of GPBB was measured in peripheral blood that was sampled 5 min before and 10, 30 and 60 min after ESET. Results: There was significant increase of GPBB concentration after the test (p = 0.021). Significant increase was detected 30 min (34.9% increase, p = 0.021) and 60 min (34.5% increase, p = 0.016) after ESET. There was no significant effect of myocardial ischemia on GPBB concentrations (p = 0.126), and no significant interaction between sampling intervals and myocardial ischemia, suggesting a similar release profile of GPBB in ischemic and non-ischemic conditions (p = 0.558). Patients in whom ESET was terminated later (stages 4 or 5 of standard Bruce protocol; n = 13) had higher GPBB concentrations than patients who terminated ESET earlier (stages 1, 2 or 3; n = 33) (p = 0.049). Baseline GPBB concentration was not correlated to any of the patients' demographic, clinical and hemodynamic characteristics. Conclusions: GPBB plasma concentration increases after ESET, and it is not related to inducible myocardial ischemia. However, it seems that GPBB release during ESET might be related to exercise load/duration. - Some of the metrics are blocked by yourconsent settings
Publication Multimodality imaging for the management of patients with primary mitral regurgitation(2022) ;Vratonjic, Jelena (57216883910) ;Jovanovic, Ivana (57223117334) ;Petrovic, Olga (33467955000) ;Paunovic, Ivana (57197090935) ;Boricic-Kostic, Marija (36191774200) ;Tesic, Milorad (36197477200) ;Nedeljkovic-Arsenovic, Olga (57191857920) ;Maksimovic, Ruzica (55921156500) ;Ivanovic, Branislava (24169010000)Trifunovic-Zamaklar, Danijela (9241771000)Advanced cardiac imaging (ACI), including myocardial deformation imaging, 3D echocardiography and cardiac magnetic resonance, overcomes the limitations of conventional echocardiography in the assessment of patients with primary mitral regurgitation (MR). They enable a more precise MR quantification and reveal early changes before advanced and irreversible remodeling with depressed heart function occurs. ACI permits a thorough analysis of mitral valvular anatomy and MR mechanisms (important for planning and guiding percutaneous and surgical procedures) and helps to identify structural and functional changes coupled with a high arrhythmogenic potential, especially the occurrence of atrial fibrillation and heart failure development. The key question is how the data provided by ACI can improve the current management of primary MR. © 2022 Wiley Periodicals LLC. - Some of the metrics are blocked by yourconsent settings
Publication Predictors of diastolic deceleration time of coronary flow velocity of infarct related and reference coronary artery assessed by transthoracic Doppler echocardiography in the chronic phase of successfully reperfused anterior myocardial infarction: relation to infarct size(2023) ;Giga, Vojislav (55924460200) ;Tesic, Milorad (36197477200) ;Beleslin, Branko (6701355424) ;Boskovic, Nikola (6508290354) ;Sobic-Saranovic, Dragana (57202567582) ;Jovanovic, Ivana (57223117334) ;Nedeljkovic, Ivana (55927577700) ;Paunovic, Ivana (57197090935) ;Dedic, Srdjan (57205504571)Djordjevic-Dikic, Ana (57003143600)Introduction: High-frequency transthoracic Doppler echocardiography (TDE) enables the assessment of flow velocity and velocity pattern in different coronary arteries, including the assessment of diastolic deceleration time (DDT) of coronary flow velocity. Short DDT of infarct related artery (IRA) (<600 msec) in the acute phase of anterior myocardial infarction (MI) is the predictor of adverse left ventricular (LV) remodeling and prognosis. The significance of DDT of coronary flow velocity assessment in the chronic phase of anterior MI is not well established. Our study aimed to establish the predictors of DDT of the coronary flow velocity of infarct related (left anterior descendent-DDT of LAD) and reference coronary artery, evaluated by TDE, and to assess their relation to infarct size in the chronic phase of successfully reperfused first anterior MI. Methods: Our study included 40 consecutive patients (34 men, mean age 52 ± 12 years) one month after the first anterior STEMI and single vessel disease successfully treated with primary PCI. All patients underwent SPECT MPI for the assessment of LV volumes, ejection fraction, and percentage of the myocardium with fixed perfusion abnormalities and echocardiographic examination including the evaluation of DDT of IRA and reference coronary artery TDE. Results: DDT of LAD correlated significantly to the WMSI (r = −0.467, p = 0.002), LV end-systolic volume (r = −0.412, p = 0.008), LV ejection fraction (r = 0.427, p = 0.006), while the strongest correlation was observed between DDT of LAD and the extent of fixed perfusion abnormality (r = −0.627, p < 0.0001), Multivariate analysis revealed percentage of fixed perfusion abnormalities along with DDT of reference coronary artery as the independent predictors of DDT of IRA. DDT of IRA shorter than 886 msec predicts large fixed perfusion abnormalities (>20%) with a sensitivity of 89% and specificity of 62% (AUC 0.842). Conclusion: DDT of LAD assessed by TDE in the chronic phase of successfully reperfused first anterior MI is a usefull variable for the assessment of microcirculatory function that exclusively reflects the extent of microvascular damage and relates to infarct size. 2023 Giga, Tesic, Beleslin, Boskovic, Sobic-Saranovic, Jovanovic, Nedeljkovic, Paunovic, Dedic and Djordjevic-Dikic. - Some of the metrics are blocked by yourconsent settings
Publication Role of different echocardiographic modalities in the assessment of microvascular function in women with ischemia and no obstructive coronary arteries(2022) ;Jovanovic, Ivana (57223117334) ;Tesic, Milorad (36197477200) ;Djordjevic-Dikic, Ana (57003143600) ;Giga, Vojislav (55924460200) ;Beleslin, Branko (6701355424) ;Aleksandric, Srdjan (35274271700) ;Boskovic, Nikola (6508290354) ;Petrovic, Olga (33467955000) ;Marjanovic, Marija (56437423000) ;Vratonjic, Jelena (57216883910) ;Paunovic, Ivana (57197090935) ;Ivanovic, Branislava (24169010000)Trifunovic-Zamaklar, Danijela (9241771000)This review summarizes current knowledge about echocardiographic modalities used to assess microvascular function and left ventricular (LV) systolic function in women with ischemia and no obstructive coronary arteries (INOCA). Although the entire pathophysiological background of this clinical entity still remains elusive, it is primarily linked to microvascular dysfunction which can be assessed by coronary flow velocity reserve. Subtle impairments of LV systolic function in women with INOCA are difficult to assess by interpretation of wall motion abnormalities. LV longitudinal function impairment is considered to be an early marker of subclinical systolic dysfunction and can be assessed by global longitudinal strain quantification. © 2022 Wiley Periodicals LLC.
